STING1 and Cirrhosis: This study reveals the crucial role of hepatic EVs in promoting skeletal muscle inflammation injury during cirrhosis and highlights that targeted inhibition of hepatic EV secretion or STING signaling constitutes a potential therapeutic approach for preventing cirrhosis‐associated muscle atrophy.